EZH2 and breast cancer: LncRNA ANCR mediates the instability of EZH2 by enhancing the level of phosphorylation at both Thr‐345 and Thr‐487 in breast cancer cells, with concomitant inhibition of breast cancer cell motility.[38] However, the details of how ANCR physically interacts with EZH2 remain unclear.